AI assistant
Novonesis AS — Director's Dealing 2026
Mar 26, 2026
3377_rns_2026-03-26_6caa695b-77f0-486b-bc5d-6404dddaec0c.pdf
Director's Dealing
Open in viewerOpens in your device viewer
novonesis
Trading by management and close relations of management
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the "Market Abuse Regulation") and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novonesis reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B.
March 26, 2026
Company announcement No. 10
Contact information
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
|---|---|---|---|
| a) | Name | Claus Crone Fuglsang | |
| 2. | Reason for the notification | ||
| a) | Position/status | Executive Vice President, Chief Scientific Officer | |
| b) | Initial notification/Amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Novozymes A/S | |
| b) | LEI | 529900T6WNZXD2R3JW38 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | ||
| Identification code | B-Shares | ||
| DK0060336014 | |||
| b) | Nature of the transaction | Sale of shares | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 371.80 | 400 shares | ||
| DKK 372.10 | 400 shares | ||
| DKK 372.20 | 400 shares | ||
| DKK 372.21 | 5069 shares | ||
| d) | Aggregated information | ||
| - Aggregated volume | |||
| - Price | Number of shares: 6269 | ||
| Average price, DKK: 372.1762 | |||
| Transaction value, DKK: 2,333,172.48 | |||
| e) | Date of transaction | March 25, 2026 | |
| f) | Place of the transaction | Nasdaq Copenhagen |
Tobias Bjorklund
+45 3077 8682
[email protected]
Anders Enevoldsen
+45 5350 1453
[email protected]
About Novonesis
Novonesis is a global leading biosolutions company transforming the way we all produce, consume and live. In more than 30 industries our biosolutions are helping companies meet their business needs and the needs of our planet. Our 10,000 people worldwide work closely with our partners and customers to challenge conventional thinking and transform business with biology.
Novozymes A/S, part of
Novonesis Group
Krogshoejvej 36
2880 Bagsvaerd
Denmark
cvR number: 10 00 71 27 – LEI: 529900T6WNZXD2R3JW38
novonesis.com